An O-methylflavone from Artemisia afra kills non-replicating hypoxic Mycobacterium tuberculosis

被引:3
|
作者
Kellogg, Joshua J. [1 ]
Alonso, Maria Natalia [2 ]
Jordan, R. Teal [1 ]
Xiao, Junpei [3 ]
Cafiero, Juan Hilario [2 ]
Bush, Trevor [2 ]
Chen, Xiaoling [1 ]
Towler, Melissa [2 ]
Weathers, Pamela [2 ]
Shell, Scarlet S. [2 ]
机构
[1] Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA
[2] Worcester Polytech Inst, Dept Biol & Biotechnol, Worcester, MA 01609 USA
[3] Worcester Polytech Inst, Program Bioinformat & Computat Biol, Worcester, MA 01609 USA
基金
美国食品与农业研究所; 美国国家卫生研究院;
关键词
Tuberculosis; Biochemometrics; Metabolomics; Artemisia afra; Infectious disease; Hypoxia; NATURAL-PRODUCTS; BIOCHEMOMETRICS; MODEL; SOUTH; MICE;
D O I
10.1016/j.jep.2024.118500
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Ethnopharmacological relevance: African wormwood ( Artemisia afra Jacq. ex Willd.) has been used traditionally in southern Africa to treat illnesses causing fever and was recently shown to possess anti -tuberculosis activity. As tuberculosis is an endemic cause of fever in southern Africa, this suggests that the anti -tubercular activity of A . afra may have contributed to its traditional medicinal use. Aim of the study: Tuberculosis, caused by Mycobacterium tuberculosis (Mtb), is a deadly and debilitating disease globally affecting millions annually. Emerging drug -resistant Mtb strains endanger the efficacy of the current therapies employed to treat tuberculosis; therefore, there is an urgent need to develop novel drugs to combat this disease. Given the reported activity of A. afra against Mtb, we sought to determine the mechanisms by which A. afra inhibits and kills this bacterium. Materials and methods: We used transcriptomics to investigate the impact of Artemisia spp. extracts on Mtb physiology. We then used chromatographic fractionation and biochemometric analyses to identify a bioactive fractions of A. afra extracts and identify an active compound. Results: Transcriptomic analysis revealed that A. afra exerts different effects on Mtb compared to A. annua or artemisinin, suggesting that A. afra possesses other phytochemicals with unique modes of action. A biochemometric study of A. afra resulted in the isolation of an O-methylflavone ( 1 ), 5-hydroxy-7-methoxy-2-(4methoxyphenyl)chromen-4-one, which displayed considerable activity against Mtb strain mc 2 6230 in both log phase growth and metabolically downshifted hypoxic cultures. Conclusions: The present study demonstrated that an O-methylflavone constituent of Artemisia afra explains part of the activity of this plant against Mtb. This result contributes to a mechanistic understanding of the reported anti -tubercular activity of A. afra and highlights the need for further study of this traditional medicinal plant and its active compounds.
引用
收藏
页数:8
相关论文
共 28 条
  • [1] Identification of Active Compounds from Artemisa annua and A. afra Extract That Affects Non-replicating Hypoxic Tuberculosis
    Weathers, P.
    Kellogg, J.
    Alonso, M.
    Jordan, R. T.
    Xiao, J.
    Cafiero, J.
    Bush, T.
    Chen, X.
    Towler, M.
    Shell, S.
    IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, 2024, 60 (01) : S130 - S131
  • [2] Antimycobacterial activity of pyrazinoate prodrugs in replicating and non-replicating Mycobacterium tuberculosis
    Segretti, Natanael Dante
    Simoes, Cristina Kortstee
    Correa, Michelle Fidelis
    Andres Felli, Veni Maria
    Miyata, Marcelo
    Cho, Sang Hyun
    Franzblau, Scott Gary
    dos Santos Fernandes, Joao Paulo
    TUBERCULOSIS, 2016, 99 : 11 - 16
  • [3] A class of hydrazones are active against non-replicating Mycobacterium tuberculosis
    Bonnett, Shilah A.
    Dennison, Devon
    Files, Megan
    Bajpai, Anumita
    Parish, Tanya
    PLOS ONE, 2018, 13 (10):
  • [4] Killing of non-replicating Mycobacterium tuberculosis by 8-hydroxyquinoline
    Darby, Crystal M.
    Nathan, Carl F.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 (07) : 1424 - 1427
  • [5] Gene expression profile of Mycobacterium tuberculosis in a non-replicating state
    Muttucumaru, DGN
    Roberts, G
    Hinds, J
    Stabler, RA
    Parish, T
    TUBERCULOSIS, 2004, 84 (3-4) : 239 - 246
  • [6] InhA inhibitors have activity against non-replicating Mycobacterium tuberculosis
    Flint, Lindsay
    Korkegian, Aaron
    Parish, Tanya
    PLOS ONE, 2020, 15 (11):
  • [7] Hypoxic Non-replicating Persistent Mycobacterium tuberculosis Develops Thickened Outer Layer That Helps in Restricting Rifampicin Entry
    Jakkala, Kishor
    Ajitkumar, Parthasarathi
    FRONTIERS IN MICROBIOLOGY, 2019, 10
  • [8] Transcriptional and Physiological Changes during Mycobacterium tuberculosis Reactivation from Non-replicating Persistence
    Du, Peicheng
    Sohaskey, Charles D.
    Shi, Lanbo
    FRONTIERS IN MICROBIOLOGY, 2016, 7
  • [9] 6-Hydrogen-8-Methylquinolones Active Against Replicating and Non-replicating Mycobacterium tuberculosis
    Tabarrini, Oriana
    Sabatini, Stefano
    Massari, Serena
    Pieroni, Marco
    Franzblau, Scott G.
    Cecchetti, Violetta
    CHEMICAL BIOLOGY & DRUG DESIGN, 2012, 80 (05) : 781 - 786
  • [10] A Chemical Genetics Approach to Identify Essential Functions in Non-Replicating Mycobacterium tuberculosis
    Grant, S. S.
    Stanley, S. A.
    Hung, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181